Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6984)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2013 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lei JY, Wang WT, Yan LN. Up-to-seven criteria for hepatocellular carcinoma liver transplantation: A single center analysis. World J Gastroenterol 2013; 19(36): 6077-6083 [PMID: 24106409 DOI: 10.3748/wjg.v19.i36.6077] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i36/6077.htm |
| Number | Citing Articles |
| 1 |
Simon Gray, Angela Lamarca, Mairéad G. McNamara, Julien Edeline, Karen Piper‐Hanley, Juan W. Valle, Richard A. Hubner. Prognostic and predictive factors for locoregional and systemic therapies in hepatocellular carcinoma. Liver Cancer International 2023; 4(1): 13 doi: 10.1002/lci2.62
|
| 2 |
Arno Kornberg, Ulrike Witt, Martina Schernhammer, Jennifer Kornberg, Gueralp O. Ceyhan, Katharina Mueller, Helmut Friess, Katharina Thrum. Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14430-9
|
| 3 |
Bianca Magro, Domenico Pinelli, Massimo De Giorgio, Maria Grazia Lucà, Arianna Ghirardi, Alessandra Carrobio, Giuseppe Baronio, Luca Del Prete, Franck Nounamo, Andrea Gianatti, Michele Colledan, Stefano Fagiuoli. Pre-Transplant Alpha-Fetoprotein > 25.5 and Its Dynamic on Waitlist Are Predictors of HCC Recurrence after Liver Transplantation for Patients Meeting Milan Criteria. Cancers 2021; 13(23): 5976 doi: 10.3390/cancers13235976
|
| 4 |
John C McVey, Kazunari Sasaki, Daniel J Firl. Risk assessment criteria in liver transplantation for hepatocellular carcinoma: proposal to improve transplant oncology. Hepatic Oncology 2020; 7(3) doi: 10.2217/hep-2020-0003
|
| 5 |
Volkan Ince, Tevfik Tolga Sahin, Sami Akbulut, Sezai Yilmaz. Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteria. World Journal of Clinical Cases 2022; 10(29): 10413-10427 doi: 10.12998/wjcc.v10.i29.10413
|
| 6 |
Ashok Thorat, Long-Bin Jeng, Horng-Ren Yang, Chun-Chieh Yeh, Shih-Chao Hsu, Te-Hung Chen, Kin-Shing Poon. Assessing the role of everolimus in reducing hepatocellular carcinoma recurrence after living donor liver transplantation for patients within the UCSF criteria: re-inventing the role of mammalian target of rapamycin inhibitors. Annals of Hepato-Biliary-Pancreatic Surgery 2017; 21(4): 205 doi: 10.14701/ahbps.2017.21.4.205
|
| 7 |
George Lau, Shuntaro Obi, Jian Zhou, Ryosuke Tateishi, Shukui Qin, Haitao Zhao, Motoyuki Otsuka, Sadahisa Ogasawara, Jacob George, Pierce K. H. Chow, Jianqiang Cai, Shuichiro Shiina, Naoya Kato, Osamu Yokosuka, Kyoko Oura, Thomas Yau, Stephen L. Chan, Ming Kuang, Yoshiyuki Ueno, Minshan Chen, Ann-Lii Cheng, Gregory Cheng, Wan-Long Chuang, Oidov Baatarkhuu, Feng Bi, Yock Young Dan, Rino A. Gani, Atsushi Tanaka, Wasim Jafri, Ji-Dong Jia, Jia-Horng Kao, Kiyoshi Hasegawa, Patrick Lau, Jeong Min Lee, Jun Liang, Zhenwen Liu, Yinying Lu, Hongming Pan, Diana A. Payawal, Salimur Rahman, Jinsil Seong, Feng Shen, Gamal Shiha, Tianqiang Song, Hui-Chuan Sun, Tsutomu Masaki, Ekaphop Sirachainan, Lai Wei, Jin Mo Yang, Jose D. Sallano, Yanqiao Zhang, Tawesak Tanwandee, AKadir Dokmeci, Shu-sen Zheng, Jia fan, Sheung-Tat Fan, Shiv Kumar Sarin, Masao Omata. APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024. Hepatology International 2024; doi: 10.1007/s12072-024-10732-z
|
| 8 |
Guergana Panayotova, Keri E Lunsford, Nyan L Latt, Flavio Paterno, James V Guarrera, Nikolaos Pyrsopoulos. Expanding indications for liver transplantation in the era of liver transplant oncology. World Journal of Gastrointestinal Surgery 2021; 13(5): 392-405 doi: 10.4240/wjgs.v13.i5.392
|
| 9 |
|
| 10 |
L. Jiang, J.Y. Lei, W.T. Wang, L.N. Yan, B. Li, T.F. Wen, M.Q. Xu, J.Y. Yang, Y.G. Wei. Immediate Radical Therapy or Conservative Treatments When Meeting the Milan Criteria for Advanced HCC Patients After Successful TACE. Journal of Gastrointestinal Surgery 2014; 18(6): 1125 doi: 10.1007/s11605-014-2508-2
|
| 11 |
Duilio Pagano, Simone Khouzam, Bianca Magro, Marco Barbara, Davide Cintorino, Fabrizio di Francesco, Sergio Li Petri, Pasquale Bonsignore, Sergio Calamia, Giacomo Deiro, Calogero Cammà, Marco Canzonieri, Salvatore Gruttadauria. How important is the role of iterative liver direct surgery in patients with hepatocellular carcinoma for a transplant center located in an area with a low rate of deceased donation?. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.929607
|
| 12 |
Hanaa Hibishy Gaballah, Soha Said Zakaria, Saber Abdelrahman Ismail. Activity and Expression Pattern of NF-κB/P65 in Peripheral Blood from Hepatocellular Carcinoma Patients - Link to Hypoxia Inducible Factor -1α. Asian Pacific Journal of Cancer Prevention 2014; 15(16): 6911 doi: 10.7314/APJCP.2014.15.16.6911
|
| 13 |
Marta Guerrero-Misas, Manuel Rodríguez-Perálvarez, Manuel De la Mata. Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World Journal of Hepatology 2015; 7(4): 649-661 doi: 10.4254/wjh.v7.i4.649
|
| 14 |
Zhan‐cheng Qiu, You‐wei Wu, Wei‐li Qi, Chuan Li. PIVKA‐II combined with tumor burden score to predict long‐term outcomes of AFP‐negative hepatocellular carcinoma patients after liver resection. Cancer Medicine 2024; 13(1) doi: 10.1002/cam4.6835
|
| 15 |
Parissa Tabrizian, Adriana Pero, Myron Schwartz. Hepatic Resection for Hepatocellular Carcinoma. Clinics in Liver Disease 2024; doi: 10.1016/j.cld.2024.08.008
|
| 16 |
Chase J. Wehrle, Jiro Kusakabe, Miho Akabane, Marianna Maspero, Bobby Zervos, Jamak Modaresi Esfeh, Maureen Whitsett Linganna, Yuki Imaoka, Mazhar Khalil, Alejandro Pita, Jaekeun Kim, Teresa Diago-Uso, Masato Fujiki, Bijan Eghtesad, Cristiano Quintini, Choon David Kwon, Antonio Pinna, Federico Aucejo, Charles Miller, Vincenzo Mazzaferro, Andrea Schlegel, Kazunari Sasaki, Koji Hashimoto. Expanding Selection Criteria in Deceased Donor Liver Transplantation for Hepatocellular Carcinoma: Long-term Follow-up of a National Registry and 2 Transplant Centers. Transplantation 2024; 108(12): 2386 doi: 10.1097/TP.0000000000005097
|
| 17 |
Mehmet Haluk Morgul, Philipp Felgendreff, Andreas Kienlein, Ulrich Gauger, Katrin Semmling, Hans-Michael Hau, Hans-Michael Tautenhahn, Michael Bartels. Milan criteria in the MELD era—is it justifiable to extend the limits for orthotopic liver transplantation?. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01932-6
|
| 18 |
Chang-Yi Lu, Chih-Yang Hsiao, Pey-Jey Peng, Shao-Chang Huang, Meng-Rong Chuang, Hung-Ju Su, Kai-Wen Huang. DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma. Cancers 2023; 15(18): 4465 doi: 10.3390/cancers15184465
|
| 19 |
Maria Gonçalves-Reis, Daniela Proença, Laura P. Frazão, João L. Neto, Sílvia Silva, Hugo Pinto-Marques, José B. Pereira-Leal, Joana Cardoso. Analytical validation and algorithm improvement of HepatoPredict kit to assess hepatocellular carcinoma prognosis before a liver transplantation. Practical Laboratory Medicine 2024; 39: e00365 doi: 10.1016/j.plabm.2024.e00365
|
| 20 |
S. E. Voskanyan, E. V. Naidenov, A. I. Artemiev, I. Yu. Kolyshev, D. A. Zabezhinsky, K. K. Gubarev, V. S. Rudakov, M. V. Shabalin, A. I. Sushkov, M. V. Popov, D. S. Svetlakova, A. P. Maltseva, M. Muktarzhan, Z. Sadykhov, E. V. Vidmer. Long-term results of liver transplantation for hepatocellular cancer. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2021; 26(2): 68 doi: 10.16931/10.16931/1995-5464.2021-2-68-82
|
| 21 |
Ger Koek, Sophia M. Schmitz, Jan Bednarsch, Daniel Heise, Thomas Longerich, Frank Bakers, Christian Trautwein, Tom Luedde, Tom Florian Ulmer, Ulf Peter Neumann. Living-Donor Liver Transplantation for a Large Hepatocellular Carcinoma in a Genetically Identical Twin Sister. Zeitschrift für Gastroenterologie 2024; 62(01): 56 doi: 10.1055/a-2214-1712
|
| 22 |
F.J. León Díaz, J.A. Pérez Daga, B. Sánchez Pérez, J.L. Fernández Aguilar, C. Montiel Casado, J.M. Aranda Narváez, M.A. Suárez Muñoz, L. Romacho López, J. Santoyo Villalba, J. Santoyo Santoyo. Up-to-7 Criteria for Hepatocellular Carcinoma Liver Transplantation: A Retrospective Analysis of Experiences. Transplantation Proceedings 2016; 48(9): 2969 doi: 10.1016/j.transproceed.2016.08.035
|
| 23 |
Kyung-Suk Suh, Hae Won Lee. Liver Transplantation for Advanced Hepatocellular Carcinoma: How Far Can We Go?. Hepatic Oncology 2015; 2(1): 19 doi: 10.2217/hep.14.34
|
| 24 |
Guilherme Moura Cunha, Mojgan Hosseini, Alessandro Furlan, Kathryn J. Fowler. Hepatocellular Carcinoma Staging: Differences Between Radiologic and Pathologic Systems and Relevance to Patient Selection and Outcomes in Liver Transplantation. American Journal of Roentgenology 2022; 218(1): 77 doi: 10.2214/AJR.21.26436
|
| 25 |
Marie Decraecker, Caroline Toulouse, Jean-Frédéric Blanc. Is There Still a Place for Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma at the Time of Immunotherapies? A Focus on Lenvatinib. Cancers 2021; 13(24): 6310 doi: 10.3390/cancers13246310
|
| 26 |
Islam B. Mohamed, Ahmed El Sabagh, Fuad ZainAloor, Mohamed El Talkhan, Zahraa Al lami, Megha Bhongade, Shilpa Jain, Prasun K. Jalal. Hepatology. 2025; : 1181 doi: 10.1016/B978-0-443-26711-6.00041-X
|
| 27 |
Haniee Chung, William C Chapman. Liver transplantation for hepatocellular carcinoma: how far have we come and what is the future?. Hepatic Oncology 2014; 1(3): 309 doi: 10.2217/hep.14.8
|
| 28 |
Jiliang Feng, Ruidong Zhu, Dezhao Feng, Lu Yu, Dawei Zhao, Jushan Wu, Chunwang Yuan, Junmei Chen, Yan Zhang, Xiu Zheng. Prediction of Early Recurrence of Solitary Hepatocellular Carcinoma after Orthotopic Liver Transplantation. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52427-8
|
| 29 |
Stefania Brozzetti, Simone Bini, Chiara D’Alterio, Chiara De Lucia, Leonardo Luca Chiarella, Katia Fazzi, Michele Di Martino. Liver Disease and Surgery [Working Title]. 2019; doi: 10.5772/intechopen.86638
|
| 30 |
Alexander Clevewood Ng. Stick to Milan: Infeasibility of the Brazil-Milan Criteria in recommending patients with hepatocellular carcinoma for liver transplantation. Annals of Hepatology 2021; 25: 100537 doi: 10.1016/j.aohep.2021.100537
|
| 31 |
Jiliang Feng, Junmei Chen, Ruidong Zhu, Lu Yu, Yan Zhang, Dezhao Feng, Heli Kong, Chenzhao Song, Hui Xia, Jushan Wu, Dawei Zhao. Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resection. Oncotarget 2017; 8(38): 63299 doi: 10.18632/oncotarget.18799
|
| 32 |
Daniel P. Milgrom, Mary A. Maluccio, Leonidas G. Koniaris. Management of Hepatocellular Carcinoma (HCC). Current Surgery Reports 2016; 4(6) doi: 10.1007/s40137-016-0143-4
|
| 33 |
T. K. Chattopadhyay. GI Surgery Annual. GI Surgery Annual 2018; 24: 177 doi: 10.1007/978-981-13-0161-2_8
|
| 34 |
Chuan Hao Gui, Samantha Baey, Reuban Toby D'cruz, Vishal G. Shelat. Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma – A meta-analysis. European Journal of Surgical Oncology 2020; 46(5): 763 doi: 10.1016/j.ejso.2020.01.004
|
| 35 |
Gergely Nagy, Zsuzsanna Gerlei, Anita Haboub-Sandil, Dénes Görög, József Szabó, László Kóbori, Gergely Huszty, László Bihari, Balázs Rózsa, Balázs Pőcze, Zoltán Máthé, László Piros. Optimizing Survival for Hepatocellular Carcinoma After Liver Transplantation: A Single-Center Report and Current Perspectives. Transplantation Proceedings 2022; 54(9): 2593 doi: 10.1016/j.transproceed.2022.10.048
|
| 36 |
Hari Krishna Kanduri, Aili xire, Sai Charan Goud Kurelli, Sanawar Abbas, Jian Wang, Wenya Liu. Role of imaging in pre-hepatic transplantation evaluation. Radiology of Infectious Diseases 2019; 6(4): 133 doi: 10.1016/j.jrid.2020.02.004
|
| 37 |
Li-ying Wang, Shu-sen Zheng. Advances in predicting the prognosis of hepatocellular carcinoma recipients after liver transplantation. Journal of Zhejiang University-SCIENCE B 2018; 19(7): 497 doi: 10.1631/jzus.B1700156
|
| 38 |
Dimitrios Papaconstantinou, D. Brock Hewitt, Zachary J. Brown, Dimitrios Schizas, Diamantis I. Tsilimigras, Timothy M. Pawlik. Patient stratification in hepatocellular carcinoma: impact on choice of therapy. Expert Review of Anticancer Therapy 2022; 22(3): 297 doi: 10.1080/14737140.2022.2041415
|
| 39 |
Yang Hai, Esika Savsani, Weelic Chong, John Eisenbrey, Andrej Lyshchik. Meta-analysis and systematic review of contrast-enhanced ultrasound in evaluating the treatment response after locoregional therapy of hepatocellular carcinoma. Abdominal Radiology 2021; 46(11): 5162 doi: 10.1007/s00261-021-03248-9
|